doi: 10.1080/19490976.2022.2038856 Summary Keywords gut microbiota, metabolite, cardiovascular disease, trimethylamine N-oxide, targeted therapy Citation Zhen J, Zhou Z, He M, Han H-X, Lv E-H, Wen P-B, Liu X, Wang Y-T, Cai X-C, Tian J-Q, Zhang M-Y, Xiao L and Kang X-X (2023) The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases
Prilepskaya VN, Serov VN, Zharov EV, et al
NADPH, one product of the G6PD reaction, is a potent quasicompetitive inhibitor, and because most of the coenzyme in cells is in the reduced form, it can be assumed that G6PD is normally under strong inhibition
While supplementation can be beneficial, factors such as diet, sleep, lifestyle and overall health also play an important role in maintaining healthy glutathione levels
doi: 10.1039/C9RA03848E 143 XingF.HuQ.QinY.XuJ.ZhangB.YuX.et al